New Market Study Published: Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2013
Global Markets Direct's, 'Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Syncytial Virus (RSV) Infections. Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, Half Year is built using data and information sourced...
View full press release